Abstract:The expression and methylation of p15INK4B gene and the expression of DNA methyltransferase genes (DNMTs) in the mononuclear cells (MNCs) from bone marrow of 54 cases with hematopoietic malignances were detected by using RT-PCR, Western blot, and methylation-specific PCR. Of the 54 patients, 10 cases were low-risk MDS, 10 cases were high-risk MDS, 10 cases were acute myeloid leukemia (AML), 10 cases were acute lymphocytic leukemia (ALL), 10 cases were chronic myeloid leukemia in chronic phase (CML-CP), and 4 cases were CML in blast phase (CML-BP). 10 normal persons were studied as nective controls. The results showed that the incidence of p15INK4B methylation in cells of high-risk MDS was higher than that in low-risk MDS (6/10 VS 1/10, P=0.003), and the p15INK4B methylation was found to be associated with the down-regulation of the expressions of p15INK4B gene on both mRNA (r=−0.734, p<0.001) and protein (r=−0.664, p=0.001)levels, which indicated that the silencing of p15INK4B gene was in conjunction with hypermethylation in MDS. The expressions of p15INK4B on mRNA level and protein levels were almost detected in the MNCs from bone marrow of normal persons without the p15INK4B methylation. We also found the expression of DNMT3A and DNMT3B in high-risk MDS (densitometry readings respectively: 0.624±0.146, 0.577±0.344) were higher than in low-risk MDS (densitometry readings respectively: 0.487±0.300, 0.338±0.290) (P<0.05). The expression of DNMT1 was higher in the groups of low-risk MDS, high-risk MDS, AL and CML-CP( densitometry readings respectively: 0.487±0.218, 0.697±0.243, 0.706±0.463 and 0.867±0.375) than in normal control (densitometry reading: 0.181±0.312)(P<0.05, figure listed bellow), which indicated that up-regulated DNMTS might contribute to the hypermethylation of p15INK4B, and the higher expressions of de novo methyltransferases DNMT3A and DNMT3B may be related to the disease progression of MDS. The methylation of p15INK4B was also detected in 9/20 of AL cases accompanied by over-expressions of DNMT1, DNMT3A, and DNMT3B (densitometry readings respectively: 0.706±0.463, 1.066±0.547, and 0.530±0.428). The methylation of p15INK4B was detected in 1 of 10 cases of CML-CP patients, but all be detected in 4 case of CML-BP patients. These results indicated that the hypermethylation of p15INK4B gene may be one of the most common genetic event in pathogenesis of high-risk MDS, acute leukemia, and blast phase of CML. Furthermore, DNMT3A and DNMT3B were substantially over-expressed in the bone marrow cells of these patients. which might play an important role in the transformation from MDS to acute leukemia.

Methylation of DAPK1 Gene Promoter's CpG Island and Its Role in the Pathogenic Mechanism of Leukemia

Study on Methylation of P15ink4b Gene and Its Mechanisms in Patients with Myelodysplastic Syndrome and Leukemia.

Methylation Analysis of the Wnt Antagonist in Myelodysplastic Syndrome

Aberrant Methylation Of Death-Associated Protein Kinase 1 Cpg Islands In Myelodysplastic Syndromes

The Methylation Pattern of LRP15 Gene in Acute Leukemia

Abberant Promoter Hypermethylation of AKAP12 Gene in Acute Lymphoblastic Leukemia in Children

The Research of Tumor Suppressor Gene DAPK Methylation in Neoplastic Hematologic Disorder

Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study.

Prognostic Significance of DAPK Promoter Methylation in Lymphoma: A Meta-Analysis

[Research Progress on DKK1 Gene in Leukemia].

Analysis of Promoter Hypermethylation of Death-Asscciated Protein Kinase Gene in Blood from Non-Small Cell Lung Cancer Patients

Detection of Methylation of DAPK Gene Promoter in Human Bone Marrow Mesenchymal Stem Cells and Its Transformed Mutant F6 Cells

A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.

The promoter methylation of death-associated protein kinase influences expressions of its mRNA and protein in tissue of gastric cancer

Aberrant DNA Methylation in P1 Promoter Region of Tp53 Gene in Acute Leukemia

[Hypermethylation of the Death-Associated Protein Kinase Promoter in Laryngeal Squamous Cell Cancer].

Clinical and prognostic significance of ABO promotor methylation level in adult leukemia and myelodydysplastic syndrome

The Prognostic Value of DAPK1 Hypermethylation in Gliomas: A Site-Specific Analysis.

The polymorphism and whole-genome DNA methylation level of DNMT 1 gene in acute leukemia children

Digital Loop-Mediated Isothermal Amplification-Based Absolute Methylation Quantification Revealed Hypermethylated DAPK1 in Cervical Cancer Patients

Promoter Methylation Induced Epigenetic Silencing of DAZAP2, a Downstream Effector of P38/mapk Pathway, in Multiple Myeloma Cells.